| Document Date: 2008-06-20 03:55:54 Open Document File Size: 97,65 KBShare Result on Facebook
City Atlanta / / Company Novartis / / Country United States / / Currency USD / / Event FDA Phase / / Facility Hospital Authority / / IndustryTerm pharmaceutical market / medical technology / / MedicalCondition chronic iron / cataracts / progressive hepatic fibrosis / neurological disorders / arthritis / local injection site disorder / chronic / thalassemia and other conditions / abdominal arthralgia / neutropenia / nausea / high-frequency hearing loss / skin rash / thrombocytopenia / concomitant disorders / liver fibrosis / vomiting / transfusion-dependent beta-thalassemia / thalassemia major / chronic iron Treatment / allergic reactions / cardiac disease / Cochrane review found dysfunction / hearing loss / acute renal failure / tinnitus / agranulocytosis / disorders / fibrosis / blood disorder / endocrine dysfunction / / MedicalTreatment chelation therapy / blood transfusion / / Organization Food and Health Bureau Hospital Authority / 47th American Society of Haematology Annual / Hospital Authority / / Person Prescott E et al. Br / / Position General / HADF classification General / / Product Exjade / Desferal / Deferiprone / / Technology http / / URL http /
SocialTag |